Ovid Therapeutics (OVID) Stock Chart & Stock Price History $0.29 0.00 (-0.49%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.29 +0.00 (+0.60%) As of 05/23/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ovid Therapeutics Stock Price Performance The Ovid Therapeutics (OVID) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 90.49%, with a year-to-date return of -69.44%. In the past month, the stock has decreased 17.76%, reflecting recent market activity. As of the latest close, Ovid Therapeutics traded at $0.29 with a market cap of $20.29 million and volume of 522,465 shares. Five years ago, the stock traded at $5.85, representing a 95.12% decrease over that period. At the time, it had a market cap of $320.31 million and a volume of 2.47 million shares. Receive OVID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.55%1 Month Performance-17.76%3 Month Performance-49.66%Year-To-Date Performance-69.44%1 Year Performance-90.49%5 Year Performance-95.12% OVID Stock Chart for Sunday, May, 25, 2025 OVID Chart by TradingView Ovid Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025$0.29$0.29-0.49%$0.29$0.28522,465 shs$20.29 million05/22/2025$0.29$0.29+0.35%$0.31$0.28330,121 shs$20.39 million05/21/2025$0.29$0.29-1.41%$0.30$0.28373,444 shs$20.32 million05/20/2025$0.30$0.29-3.75%$0.30$0.28506,009 shs$20.61 million05/19/2025$0.30$0.30-0.63%$0.30$0.29404,089 shs$21.41 million05/16/2025$0.31$0.30-0.75%$0.31$0.30481,275 shs$21.55 million05/15/2025$0.29$0.31+3.53%$0.31$0.29489,996 shs$21.71 million05/14/2025$0.29$0.29+3.11%$0.31$0.29227,221 shs$20.97 million05/13/2025$0.30$0.29-5.30%$0.33$0.29475,115 shs$20.34 million05/12/2025$0.29$0.30+4.10%$0.31$0.29311,343 shs$21.48 million Get the Latest News and Ratings for OVID and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2025$0.29$0.29-1.33%$0.30$0.28306,406 shs$20.63 million05/08/2025$0.30$0.29-1.28%$0.30$0.28187,669 shs$20.91 million05/07/2025$0.29$0.30+3.84%$0.30$0.28378,751 shs$21.18 million05/06/2025$0.30$0.29-5.87%$0.32$0.28378,789 shs$20.39 million05/05/2025$0.32$0.30-5.84%$0.33$0.30318,951 shs$21.67 million05/02/2025$0.32$0.32+2.66%$0.33$0.31245,249 shs$23 million05/01/2025$0.33$0.32-3.64%$0.34$0.31320,309 shs$22.40 million04/30/2025$0.34$0.33-3.31%$0.33$0.31459,205 shs$23.25 million04/29/2025$0.35$0.34-3.34%$0.36$0.33374,695 shs$24.05 million04/28/2025$0.35$0.35+0.89%$0.36$0.34740,526 shs$24.88 million04/25/2025$0.34$0.35+3.00%$0.35$0.32634,786 shs$24.66 million04/24/2025$0.33$0.34+3.63%$0.36$0.32761,073 shs$23.94 million Related Companies SNTI Stock Price Chart GALT Stock Price Chart ADAG Stock Price Chart PLRX Stock Price Chart OCX Stock Price Chart GNTA Stock Price Chart CRVO Stock Price Chart PYXS Stock Price Chart TELO Stock Price Chart EPIX Stock Price Chart Receive OVID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OVID) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovid Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ovid Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
